Here are five points:
1. The other researchers include:
- Miranda van Tilburg, PhD
- Douglas Drossman, MD
- Olafur Palsson, PsyD
2. The Rome Foundation is a nonprofit organization supporting people suffering from functional GI disorders.
3. Rome IV, published 10 years after Rome III, incorporates the amended guidelines Dr. Whitehead and his team proposed.
4. Irritable bowel syndrome is one GI disorder that underwent diagnostic changes. Currently, IBS affects an estimated six percent of the U.S. population. Before Rome IV’s publication, however, IBS was believed to affect an estimated 11 percent of the U.S. population.
5. Disorders published for the first time in Rome IV include functional nausea and functional vomiting for pediatrics, and cannabinoid-induced nausea and opiate-induced constipation for adults.
More articles on GI & endoscopy:
Gastroenterologist to know: Dr. John Allen of Yale Medical Group
Takeda Pharmaceutical injects 1st human subject with norovirus vaccine candidate, Healthmark Industries unveils new Endoscope Cleaning Brush — 5 GI company key notes
Zacks rates Boston Scientific stock ‘buy’: 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.